Pacific Biosciences of California (PACB) — Cash Flow-to-Debt Ratio
Pacific Biosciences of California (PACB) has a Cash Flow-to-Debt Ratio of -0.07x as of March 2026, meaning its operating cash flow of $-44.69 Million could theoretically repay 0% of its total liabilities ($677.60 Million) in one year. See PACB free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pacific Biosciences of California Cash Flow-to-Debt Ratio (2008–2025)
Historical debt coverage capacity for Pacific Biosciences of California across 18 annual periods. Also explore PACB shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Pacific Biosciences of California (2008–2025)
Year-by-year debt coverage analysis for Pacific Biosciences of California. For market capitalisation and broader financial context, see Pacific Biosciences of California stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.14x | $-111.21 Million | $778.73 Million | ▲ +47.8% |
| 2024 | -0.27x | $-206.06 Million | $753.85 Million | ▼ -7.1% |
| 2023 | -0.26x | $-266.55 Million | $1.04 Billion | ▼ -16.7% |
| 2022 | -0.22x | $-263.21 Million | $1.20 Billion | ▼ -139.1% |
| 2021 | -0.09x | $-111.18 Million | $1.22 Billion | ▼ -136.8% |
| 2020 | 0.25x | $19.50 Million | $78.49 Million | ▲ +129.5% |
| 2019 | -0.84x | $-78.31 Million | $93.07 Million | ▲ +28.8% |
| 2018 | -1.18x | $-66.43 Million | $56.21 Million | ▼ -1.5% |
| 2017 | -1.16x | $-67.52 Million | $57.98 Million | ▲ +8.8% |
| 2016 | -1.28x | $-67.93 Million | $53.22 Million | ▼ -53.4% |
| 2015 | -0.83x | $-47.89 Million | $57.57 Million | ▼ -12.5% |
| 2014 | -0.74x | $-51.47 Million | $69.57 Million | ▼ -66.2% |
| 2013 | -0.45x | $-29.83 Million | $67.00 Million | ▲ +88.2% |
| 2012 | -3.78x | $-76.82 Million | $20.30 Million | ▲ +1.3% |
| 2011 | -3.83x | $-102.97 Million | $26.85 Million | ▲ +18.6% |
| 2010 | -4.71x | $-122.00 Million | $25.88 Million | ▼ -1652.4% |
| 2009 | -0.27x | $-74.84 Million | $278.22 Million | ▼ -45.0% |
| 2008 | -0.19x | $-38.30 Million | $206.50 Million | — |